CBIO logo

Catalyst Biosciences (CBIO) Current Liabilities

Annual Current Liabilities

$16.82 M
+$2.66 M+18.77%

31 December 2022

CBIO Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Liabilities

$1.78 M
-$1.01 M-36.16%

30 September 2023

CBIO Quarterly Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CBIO Current Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--
3 y3 years+18.8%-87.4%
5 y5 years-41.8%-93.8%

CBIO Current Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years
5 y5 years
alltimeall time-83.4%-98.2%

Catalyst Biosciences Current Liabilities History

DateAnnualQuarterly
Sept 2023
-
$1.78 M(-36.2%)
June 2023
-
$2.79 M(-59.2%)
Mar 2023
-
$6.84 M(-59.3%)
Dec 2022
$16.82 M(+18.8%)
$16.82 M(+923.4%)
Sept 2022
-
$1.64 M(-61.9%)
June 2022
-
$4.31 M(-67.3%)
Mar 2022
-
$13.19 M(-6.9%)
Dec 2021
$14.16 M(-20.4%)
$14.16 M(-17.9%)
Sept 2021
-
$17.25 M(+10.8%)
June 2021
-
$15.57 M(+9.8%)
Mar 2021
-
$14.18 M(-20.3%)
Dec 2020
$17.80 M(-38.4%)
$17.80 M(+5.8%)
Sept 2020
-
$16.82 M(+23.1%)
June 2020
-
$13.66 M(+15.3%)
Mar 2020
-
$11.85 M(-59.0%)
Dec 2019
$28.90 M(+501.9%)
$28.90 M(+218.4%)
Sept 2019
-
$9.08 M(+46.5%)
June 2019
-
$6.20 M(+41.8%)
Mar 2019
-
$4.37 M(-9.0%)
Dec 2018
$4.80 M(-45.1%)
$4.80 M(+45.3%)
Sept 2018
-
$3.30 M(+35.5%)
June 2018
-
$2.44 M(-15.9%)
Mar 2018
-
$2.90 M(-66.8%)
Dec 2017
$8.74 M(-60.2%)
$8.74 M(-8.1%)
Sept 2017
-
$9.51 M(+2.4%)
June 2017
-
$9.28 M(-39.0%)
Mar 2017
-
$15.22 M(-30.7%)
Dec 2016
$21.96 M(-41.8%)
$21.96 M(-31.3%)
Sept 2016
-
$31.99 M(-4.9%)
June 2016
-
$33.63 M(+0.9%)
Mar 2016
-
$33.33 M(-11.7%)
Dec 2015
$37.76 M(+1195.7%)
$37.76 M(-0.4%)
Sept 2015
-
$37.91 M(+2207.1%)
June 2015
-
$1.64 M(-57.9%)
Mar 2015
-
$3.90 M(+33.9%)
Dec 2014
$2.91 M
$2.91 M(-9.3%)
DateAnnualQuarterly
Sept 2014
-
$3.21 M(-57.2%)
June 2014
-
$7.50 M(-24.0%)
Mar 2014
-
$9.87 M(-10.1%)
Dec 2013
$10.98 M(-3.3%)
$10.98 M(+3.2%)
Sept 2013
-
$10.64 M(+23.6%)
June 2013
-
$8.61 M(+2.8%)
Mar 2013
-
$8.37 M(-26.2%)
Dec 2012
$11.35 M(-85.6%)
$11.35 M(+15.7%)
Sept 2012
-
$9.81 M(-25.0%)
June 2012
-
$13.07 M(-72.9%)
Mar 2012
-
$48.20 M(-38.7%)
Dec 2011
$78.61 M(-20.3%)
$78.61 M(-16.0%)
Sept 2011
-
$93.58 M(+5.1%)
June 2011
-
$89.06 M(-4.6%)
Mar 2011
-
$93.35 M(-5.4%)
Dec 2010
$98.66 M(-2.5%)
$98.66 M(+3.0%)
Sept 2010
-
$95.80 M(-0.5%)
June 2010
-
$96.27 M(+13.3%)
Mar 2010
-
$84.94 M(-16.1%)
Dec 2009
$101.23 M(+634.0%)
$101.23 M(+647.6%)
Sept 2009
-
$13.54 M(+5.7%)
June 2009
-
$12.81 M(+4.5%)
Mar 2009
-
$12.26 M(-11.1%)
Dec 2008
$13.79 M(-9.2%)
$13.79 M(-3.1%)
Sept 2008
-
$14.23 M(+1.0%)
June 2008
-
$14.09 M(+3.6%)
Mar 2008
-
$13.59 M(-10.5%)
Dec 2007
$15.20 M(+69.8%)
$15.20 M(+29.5%)
Sept 2007
-
$11.73 M(+40.1%)
June 2007
-
$8.37 M(+24.8%)
Mar 2007
-
$6.71 M(-25.1%)
Dec 2006
$8.95 M(+71.8%)
$8.95 M(+23.8%)
Sept 2006
-
$7.23 M(+7.2%)
June 2006
-
$6.74 M(+30.5%)
Mar 2006
-
$5.17 M(-0.8%)
Dec 2005
$5.21 M(-1.9%)
$5.21 M
Dec 2004
$5.31 M
-

FAQ

  • What is Catalyst Biosciences annual total current liabilities?
  • What is the all time high annual current liabilities for Catalyst Biosciences?
  • What is Catalyst Biosciences quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Catalyst Biosciences?

What is Catalyst Biosciences annual total current liabilities?

The current annual current liabilities of CBIO is $16.82 M

What is the all time high annual current liabilities for Catalyst Biosciences?

Catalyst Biosciences all-time high annual total current liabilities is $101.23 M

What is Catalyst Biosciences quarterly total current liabilities?

The current quarterly current liabilities of CBIO is $1.78 M

What is the all time high quarterly current liabilities for Catalyst Biosciences?

Catalyst Biosciences all-time high quarterly total current liabilities is $101.23 M